---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-079773"
form_type: "8-K"
ticker: "TNYA"
cik: "0001858848"
company_name: "Tenaya Therapeutics, Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:50:52.802038+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Tenaya Therapeutics shareholders elect all three Class I directors and ratify Deloitte as auditor

## Summary
- David Goeddel, Ph.D. elected with 80,444,762 votes for, 8,262,596 withheld.
- Jeffrey T. Walsh elected with 70,717,277 for, 17,990,081 withheld.
- R. Sanders Williams elected with 70,410,874 for, 18,296,484 withheld.
- Ratification of Deloitte & Touche LLP passed with 120,339,858 for, 416,705 against, 192,213 abstain.
- Broker non-votes of 32,241,417 on each director nominee; none on auditor ratification.

## SEC filing metadata
- accession: 0000950170-25-079773
- form_type: 8-K
- ticker: TNYA
- cik: 0001858848
- company_name: Tenaya Therapeutics, Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858848/000095017025079773/0000950170-25-079773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858848/000095017025079773/tnya-20250528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-079773
- JSON: https://secwatch.observer/filing/0000950170-25-079773.json
- Plain text: https://secwatch.observer/filing/0000950170-25-079773.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.